|Titel||Detoxification of patients with GHB dependence.|
|Jaar van publicatie||2013|
|Auteurs||van Oene GH de Weert, Schellekens A, Dijkstra BAG, Kamal RM, DeJong CA|
BACKGROUND: A new detoxification method for ghb dependence was developed recently in the Netherlands. The method involves the use of pharmaceutical ghb.
AIM: To describe the characteristics of ghb dependent inpatients, the course of the detoxification process and patients’ progress in the three months following inpatient detoxification.
METHOD: 229 ghb dependent patients were monitored during and after inpatient detoxification. Records were kept of the psychiatric symptoms, withdrawal symptoms and relapses.
RESULTS: The average age of the patients was 29 years; 69% of the patients were male. They reported severe symptoms of co-occurring depression and anxiety. Detoxification was successful in 86% of the patients and, on a whole, the procedure ran smoothly, without complications. However, within three months following detoxification two-thirds of the patients had relapsed and were again taking ghb.
CONCLUSION: Pharmaceutical ghb can be used as an alternative to the benzodiazepine method for detoxifying patients with ghb dependence. However, the high relapse rates following detoxification are of great concern.
|Alternatieve uitgave||Tijdschr Psychiatr|